Clinical trials
Terminated Phase 1 Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Augusta University | 1 |
| Ikena Oncology | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| Numab Therapeutics AG | 1 |
| Seagen Inc. | 1 |
| University of Chicago | 1 |
| Verastem, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 11 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Melanoma | 3 |
| Sarcoma | 3 |
| Esophageal Neoplasms | 2 |
| Fallopian Tube Neoplasms | 2 |
| Liposarcoma | 2 |
| Mesothelioma | 2 |
| Ovarian Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.